FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.9  |  FHIR Version n/a  User: [n/a]

10470511000001101: Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
230221000001118 Mestinon retard 180mg tablets (Mylan) 100 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
230241000001111 Mestinon retard 180mg tablets (Mylan) 100 tablet (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2148061000001118 Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2148071000001111 Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36003501000001116 Mestinon retard 180mg modified-release tablets (Valeant Pharm) 100 tablet (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
36003601000001117 Mestinon retard 180mg modified-release tablets (Valeant Pharm) 100 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
39746801000001112 Mestinon retard 180mg tablets (Valeant Pharm) 100 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
45488401000001116 Mestinon retard 180mg tablets (Valeant Pharmaceuticals Ltd) 100 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
54269301000001117 Mestinon retard 180mg tablets (Meda Pharmaceuticals Ltd) 100 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction individual patient supply true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Is a Pyridostigmine bromide 180mg modified-release tablets 100 tablet true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Is pack of Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) false Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Has active ingredient Pyridostigmine bromide false Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Has AMP Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Has specific active ingredient Pyridostigmine bromide true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start